Microfluidics Deep Research on Industrial and Market studies: Point of Care Testing Segment Anticipated to Register High Revenue Growth over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016-2026
"Microfluidics
Market: Point of Care Testing Segment Anticipated to Register High
Revenue Growth over the Forecast Period: Global Industry Analysis and
Opportunity Assessment 2016-2026"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
With
14.5% CAGR, point of care testing segment is the largest segment
among the global microfluidics market application segments
By the end of 2026, the point of care testing
segment is projected to reach more than US$ 3,000 Mn in revenue and
is estimated to grow 3.9x by 2026 end as compared to that in 2016.
The point of care testing segment is the largest segment among the
different application segments in the global microfluidics market,
which was estimated to create close to US$ 1,000 Mn or 33.2% share of
the total market in 2016. This segment is anticipated to register a
CAGR of 14.5% over the forecast period.
Get
Sample
Report
With TOC @
http://www.researchmoz.us/enquiry.php?type=S&repid=1287928
An
increasing use of point of care testing devices is likely to drive
the growth of the point of care testing segment
Increasing demand for microfluidics technology
based point of care devices and kits in in-vitro diagnostics is
expected to propel the growth of the point of care segment over the
forecast period. Point of care testing devices have significant
applications in the field of genomics and proteomics. For instance,
these devices help identify the DNAs of microbes that are responsible
for causing various diseases and are also used in protein analysis. A
prominent feature of these devices is that these can be used at
bedside, hospitals, in the delivery room, in intensive care units, in
doctor's offices, in emergency rooms, in pharmacies, at home for
self-testing, and even in space owing to their size, disposability
and integration of complex functions. An increasing use of point of
care testing devices across various end-use industries is likely to
drive the growth of the point of care testing segment during 2016 -
2026.
Due to increase in price pressures in various
countries, companies operating in the global microfluidics market
have shifted their focus to developing low-cost diagnostic devices
that can provide accurate results in less time. Hence, point of care
microfluidics devices have gained traction over the years owing to
benefits such as low cost of development and capability to generate
accurate and reliable results rapidly. Furthermore, these devices
occupy less space and need fewer volumes of samples for analysis than
conventional diagnostic devices, thereby decreasing operational
costs. The funding that drives the development of point of care
technologies comes from multiple sources including the NIH and the
U.S. Department of Defense (DOD), as well as private foundations such
as the Bill and Melinda Gates Foundation and other pharmaceutical
industry foundations / associations.
Point of care segment is expected to
register high revenue growth in Western Europe
In North America, by application type, the point
of care testing segment is expected to register high revenue growth
and exhibit a market attractiveness index of 1.19 over the forecast
period, while in Latin America, the point of care testing segment is
projected to register high revenue growth and exhibit a market
attractiveness index of 1.48 over the forecast period. In Western
Europe, this segment is anticipated to register high revenue growth
and exhibit a market attractiveness index of 1.6 between 2016 and
2026. In Eastern Europe, the point of care testing segment is
predicted to register increased revenue growth and record a market
attractiveness index of 1.46 over the coming decade; while in APEJ,
Future Market Insights analysts estimate the point of care testing
segment to register high revenue growth, exhibiting a market
attractiveness index of 1.35 over the projected period.
Full
Report @
http://www.researchmoz.us/microfluidics-market.html
Comments
Post a Comment